Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Smart Technology Facilitated In-hospital Venous Thromboembolism Prophylaxis Based on Bundled Evidence-based Prevention Strategies: the SmaVTE-BEST Study

NCT06353373 is registered in ClinicalTrials.gov with Navy General Hospital, Beijing as lead sponsor.

NCT NCT06353373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06353373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Smart Technology Facilitated In-hospital Venous Thromboembolism Prophylaxis Based on Bundled Evidence-based Prevention Strategies: the SmaVTE-BEST Study
Lead sponsor
Navy General Hospital, Beijing
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2024
Completion date
February 28, 2025
Enrollment
15,626 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

clinical decision support systems, digital health, venous thromboembolism